Latest DEF 14A proxy statements

NYSE
Entravision Communications Corporation has issued its 2026 proxy statement, seeking shareholder approval for director elections, auditor ratification, executive compensation, and a 6-million share increase to its equity incentive plan.
NASDAQ
Dave Inc. has filed its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 2, 2026.
NYSE
KinderCare Learning Companies, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation advisory votes.
OQB
Galera Therapeutics, Inc. has entered into a definitive merger agreement with Obsidian Therapeutics, Inc. in an all-stock transaction expected to close by the third quarter of 2026.
NASDAQ
OrthoPediatrics Corp. has scheduled its 2026 annual meeting of stockholders for June 4, 2026, to address director elections, executive compensation, and an incentive plan amendment.
NASDAQ
Ceva, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory votes.
NYSE
Gates Industrial Corporation announces its 2026 Annual General Meeting, focusing on director elections, executive compensation, and auditor appointments.
NYSE
General Motors' 2026 proxy statement outlines strategic shifts in EV capacity, executive compensation adjustments, and a proposal to increase shares for its long-term incentive plan.
NASDAQ
Cibus, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 2, 2026.
NYSE
Abercrombie & Fitch reports record fiscal 2025 net sales of $5.27 billion and outlines governance and compensation plans for the upcoming annual meeting.
OQB
Charlie's Holdings, Inc. seeks shareholder approval for a reverse stock split and an increase in equity incentive plan shares to facilitate a potential national exchange uplisting.
NYSE
PennyMac Financial Services, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing director nominations, auditor ratification, and executive compensation.
NASDAQ
InspireMD, Inc. has scheduled its 2026 Annual Meeting for June 3, 2026, to elect directors and seek approval to increase authorized common stock to 250 million shares.
NASDAQ
Cipher Digital Inc. has released its 2026 proxy statement detailing director elections, executive compensation, and the ratification of its independent auditor.
NASDAQ
PTC Therapeutics, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory vote.
NYSE
Bristow Group Inc. has released its 2026 proxy statement detailing director elections, executive compensation, and a proposed increase to its equity incentive plan.
OQX
Horizon Kinetics Holding Corporation announces its 2026 Annual Meeting of Stockholders, addressing the recent passing of co-founder Murray Stahl and proposing director elections, auditor ratification, and executive compensation approval.
GPGI, Inc. has scheduled a special meeting of stockholders for June 4, 2026, to vote on reincorporating the company from Delaware to Nevada.
NASDAQ
FTAI Infrastructure Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting agenda, including director elections and auditor ratification.
NYSE
Granite Point Mortgage Trust Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 4, 2026.
NASDAQ
CVRx, Inc. has issued its proxy statement for the 2026 annual meeting of stockholders to be held virtually on June 1, 2026.
NASDAQ
Smithfield Foods, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation advisory votes.
OQX
Standard Premium Finance Holdings, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and governance amendments.
NASDAQ
Barrett Business Services, Inc. announces its 2026 Annual Meeting, seeking approval for a 1.2 million share increase to its 2020 Stock Incentive Plan.
NYSE
Bain Capital Specialty Finance, Inc. has issued its 2026 proxy statement for the annual meeting of stockholders to be held on May 21, 2026.
NASDAQ
Verrica Pharmaceuticals Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and a proposed amendment to its 2018 Equity Incentive Plan.
NASDAQ
Immuneering Corporation has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026.
NYSE
Asana, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting of stockholders scheduled for June 8, 2026.
NASDAQ
DoorDash, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation practices.
NASDAQ
Exponent, Inc. announces its 2026 Annual Meeting of Stockholders, featuring key leadership transitions and executive compensation approvals.